AbbVie: Fine, I’ll Say It

Ten years ago, they were practically begging for trouble. 63% of their revenue from one drug, Humira? That’s like building your entire life around a single, slightly unreliable toaster. Everyone knew the patents were going to expire. It was inevitable. And then what? Panic, that’s what. But they didn’t panic. Or at least, they hid it well. Which is…suspicious. People should panic more. It’s honest.








